How sleep affects Alzheimer's and related brain diseases
Deciphering the molecular interplay of sleep and neurodegeneration with Drosophila
Researchers are using fruit flies that carry a human brain protein to learn how sleep problems make Alzheimer's-style brain damage worse and to find molecules that could point to future treatments for people with Alzheimer's or related conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11257697 on NIH RePORTER |
What this research studies
Scientists are using fruit flies that express a human neurodegeneration protein (TDP‑43) to model how sleep is disrupted in brain disease. They focus on glial cells and run genetic screens in the flies to find genes and pathways that link sleep loss to brain degeneration. The team aims to identify molecular signals that change both sleep and brain health so those signals can become targets for drugs or sleep-based therapies. Findings in flies could guide follow-up studies in people with Alzheimer's, frontotemporal dementia, or other TDP‑43–related conditions.
Who could benefit from this research
Good fit: People with Alzheimer's disease, frontotemporal dementia, or other TDP‑43–related neurodegenerative conditions would be the most relevant groups for future trials informed by this work.
Not a fit: People without neurodegenerative disease or whose condition is unrelated to TDP‑43 pathology may not gain direct benefit from this research.
Why it matters
Potential benefit: Could reveal molecular targets and sleep-based approaches that slow brain degeneration or improve symptoms in people with Alzheimer's and related diseases.
How similar studies have performed: Prior human and animal research links sleep disruption to worsened dementia and implicates TDP‑43 in several dementias, but using fruit flies to map specific molecular links between sleep and degeneration is a newer approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Kayser, Matthew S — University of Pennsylvania
- Study coordinator: Kayser, Matthew S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.